Omeros Corporation (OMER)
$18.88-3.82%Close
BUYRECOVERY · day 4
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $1.4B
- Beta
- 2.57
- P/E (TTM)
- 9.88
- Short % float
- 16.31%
- Days to cover
- 7.0
- SI change
- -8.9%
- 1W
- +2.00%
- 1M
- +8.13%
- vs SPY 1W
- +2.14%
- vs SPY 1M
- +5.63%
Industry peers
FMP comparable companies · ranked by market cap
- RCUSSELLArcus Biosciences, Inc.$3.1BCRISISQ 17$24.41-7.52%
- XNCRSELLXencor, Inc.$1.8BRECOVERYQ 15$24.63-6.07%
- BHVNSELLBiohaven Ltd.$1.8BCRISISQ 16$12.08-3.30%
- ANABSELLAnaptysBio, Inc.$1.4BCRISISQ 25$45.95-0.98%
- NKTRSELLNektar Therapeutics$1.2BCRISISQ 12$41.17-4.82%
- CGEMSELLCullinan Therapeutics, Inc.$954MCRISISQ 1$15.53-5.69%
- CRVSSELLCorvus Pharmaceuticals, Inc.$885MCRISISQ 12$10.52-6.37%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 33
- VALUE
- 21
- GROWTH
- 9
- GARP
- 61
- TYPE
- Growth Compounder (blended)
Composite of Value · Growth · GARP
ROIC-65.6%
REV YoY-
ROE-109.4%
EPS YoY-
ROA43.5%
GROSS96
OP-190
NET325
[VALUATION]
P/E TTM9.88
P/E FWD20.22
SECTOR PE20.34
INDUSTRY PE13.84
P/B-26.52
P/FCF-
EV/EBITDA10.89
EV/EBIT-
PEG1.22
FCF YIELD-
RISK
INT COV-
D/E-
ALTMAN Z-
CURR RATIO1.95
ND/EBITDA-
BETA2.57
Company news
FAQ
- What is LOPJLB’s current signal on OMER?
- LOPJLB’s latest quantitative signal on Omeros Corporation (OMER) is BUY in a RECOVERY regime. Signals are updated daily.
- What market regime is OMER in?
- Omeros Corporation (OMER) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Omeros Corporation (OMER) do?
- Omeros Corporation is a biopharmaceutical firm with commercialized products, actively engaged in the discovery, development, and market introduction of both small-molecule and protein-based therapies, including treatments for rare diseases. The company's therapeutic endeavors primarily focus on inflammatory conditions, illnesses mediated by the complement system, cancers linked to immune system…